Fred Alger Management »

Aeglea Biotherapeutics shares owned by Fred Alger Management

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Fred Alger Management from 13F filings

Historical chart of Fred Alger Management investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Fred Alger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Fred Alger Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.0M 60k 50.44
2024-03-31 $689k 18k 37.93

More positions owned by Fred Alger Management

NVIDIA Corporation Equity (NVDA)
Microsoft Corporation Equity (MSFT)
Amazon.com Equity (AMZN)
Apple Equity (AAPL)
Alphabet Inc. Class C Equity (GOOG)
Meta Platforms Inc Class A Equity (META)
Nebius Group N.V. Class A Equity (NBIS)
Broadcom Equity (AVGO)
Western Digital Corporation Equity (WDC)
Tesla Equity (TSLA)
AppLovin Corp. Class A Equity (APP)
Qxo Equity (QXO)
Talen Energy Corp Equity (TLN)
Natera Equity (NTRA)
GE Vernova Equity (GEV)

View all positions for Fred Alger Management

Top funds holding Aeglea Biotherapeutics

FMR
BlackRock
Rtw Investments
Vanguard Group
Fairmount Funds Management
Perceptive Advisors
VR Adviser
Vanguard Capital Management
Driehaus Capital Management
State Street Corporation
Paradigm Biocapital Advisors
Commodore Capital
TCG Crossover Management
Tang Capital Management
Capital Research and Management Company - Division 3

View all funds holding Aeglea Biotherapeutics